Edition:
India

Acceleron Pharma Inc (XLRN.OQ)

XLRN.OQ on NASDAQ Stock Exchange Global Market

38.71USD
17 Nov 2017
Change (% chg)

$1.74 (+4.71%)
Prev Close
$36.97
Open
$36.70
Day's High
$38.84
Day's Low
$36.70
Volume
158,574
Avg. Vol
136,685
52-wk High
$40.35
52-wk Low
$23.07

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.60 December 18 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 7 7 6 6
(3) HOLD 3 3 3 2
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.07 2.07 2.07 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 10 3.73 5.66 2.76 3.69
Quarter Ending Mar-18 5 4.30 8.00 2.90 --
Year Ending Dec-17 13 13.37 14.78 12.54 39.18
Year Ending Dec-18 14 36.81 148.10 0.00 82.13
Earnings (per share)
Quarter Ending Dec-17 14 -0.60 -0.38 -0.74 -0.63
Quarter Ending Mar-18 5 -0.58 -0.47 -0.66 --
Year Ending Dec-17 12 -2.67 -2.46 -2.82 -1.77
Year Ending Dec-18 15 -2.24 0.39 -2.90 -0.79

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 4.98 3.01 1.97 39.50
Quarter Ending Jun-17 3.69 3.06 0.64 17.21
Quarter Ending Mar-17 3.91 3.70 0.20 5.13
Quarter Ending Dec-16 3.74 3.37 0.37 9.82
Quarter Ending Sep-16 4.07 3.01 1.07 26.22
Earnings (per share)
Quarter Ending Sep-17 -0.64 -0.65 0.01 -1.61
Quarter Ending Jun-17 -0.62 -0.68 0.06 -8.80
Quarter Ending Mar-17 -0.54 -0.66 0.12 -22.72
Quarter Ending Dec-16 -0.55 -0.51 0.04 -6.83
Quarter Ending Sep-16 -0.53 -0.55 0.02 -3.02

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 3.73 4.00 4.13 4.26 3.69
Quarter Ending Mar-18 4.30 4.30 3.80 3.80 --
Year Ending Dec-17 13.37 14.90 16.34 16.69 39.18
Year Ending Dec-18 36.81 38.95 38.74 39.01 82.13
Earnings (per share)
Quarter Ending Dec-17 -0.60 -0.62 -0.64 -0.66 -0.63
Quarter Ending Mar-18 -0.58 -0.58 -0.61 -0.67 --
Year Ending Dec-17 -2.67 -2.69 -2.76 -2.81 -1.77
Year Ending Dec-18 -2.24 -2.17 -2.28 -2.28 -0.79

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 1 1 6
Quarter Ending Mar-18 0 0 0 2
Year Ending Dec-17 0 1 1 10
Year Ending Dec-18 0 1 1 5
Earnings
Quarter Ending Dec-17 3 0 11 2
Quarter Ending Mar-18 0 0 1 2
Year Ending Dec-17 0 0 5 2
Year Ending Dec-18 0 1 7 6